Mirae Asset Global Investments Co., Ltd. Xenon Pharmaceuticals Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,740 shares of XENE stock, worth $125,327. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,740
Previous 2,253
21.62%
Holding current value
$125,327
Previous $87,000
22.99%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding XENE
# of Institutions
222Shares Held
69.7MCall Options Held
59.7KPut Options Held
60.7K-
Avoro Capital Advisors LLC New York, NY5.67MShares$259 Million3.02% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.42MShares$202 Million1.86% of portfolio
-
Wellington Management Group LLP Boston, MA3.83MShares$175 Million0.03% of portfolio
-
Commodore Capital LP New York, NY2.75MShares$126 Million9.63% of portfolio
-
Capital World Investors Los Angeles, CA2.68MShares$123 Million0.02% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.85B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...